Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study.
about
Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIVEffectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patientsThe effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver diseaseVirologic and immunologic effectiveness at 48 weeks of darunavir-ritonavir-based regimens in treatment-experienced persons living with HIV-1 infection in clinical practice: a multicenter Brazilian cohort.Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis.Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain.Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis.Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.
P2860
Q33589224-10F129B4-766F-4AE4-90CF-519257AEEDBBQ36091962-743B2790-9169-4546-A0B0-21ED149174DAQ36243096-78F7C00B-AA84-42D9-A7E0-DB3D0A549476Q38910036-41DFD103-D86F-4D37-BE97-93FAB328DCDDQ39932884-2B34385E-746A-42C7-8E6C-CF57075EECFBQ40662095-BC8232A5-5739-41FC-97FD-D939DB1D8BABQ40812700-3D7F7C7F-B6A3-41DC-AB00-C47F820923F2Q43601186-0D1128C7-5F79-4A9C-9BB5-AB783AAA28ACQ45036770-CBA361A9-A0E6-4DF0-A0FB-CE33B5210DB2
P2860
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Efficacy, tolerability and ris ...... s: the Swiss HIV Cohort Study.
@en
Efficacy, tolerability and ris ...... s: the Swiss HIV Cohort Study.
@nl
type
label
Efficacy, tolerability and ris ...... s: the Swiss HIV Cohort Study.
@en
Efficacy, tolerability and ris ...... s: the Swiss HIV Cohort Study.
@nl
prefLabel
Efficacy, tolerability and ris ...... s: the Swiss HIV Cohort Study.
@en
Efficacy, tolerability and ris ...... s: the Swiss HIV Cohort Study.
@nl
P2093
P2860
P1433
P1476
Efficacy, tolerability and ris ...... s: the Swiss HIV Cohort Study.
@en
P2093
A U Scherrer
B Hirschel
E Bernasconi
H C Bucher
H F Günthard
M Cavassini
P2860
P304
P356
10.1111/J.1468-1293.2010.00885.X
P577
2010-10-18T00:00:00Z